Northern Trust’s Adverum Biotechnologies ADVM Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q4 | – | Sell |
-28,058
| Closed | -$127K | – | 4451 |
|
|
2025
Q3 | $127K | Sell |
28,058
-6,333
| -18% | -$18.7K | ﹤0.01% | 4081 |
|
|
2025
Q2 | $73.9K | Sell |
34,391
-115,981
| -77% | -$324K | ﹤0.01% | 4171 |
|
|
2025
Q1 | $657K | Sell |
150,372
-2,205
| -1% | -$9.94K | ﹤0.01% | 3462 |
|
|
2024
Q4 | $713K | Sell |
152,577
-2,420
| -2% | -$16.3K | ﹤0.01% | 3528 |
|
|
2024
Q3 | $1.09M | Buy |
154,997
+107,834
| +229% | +$783K | ﹤0.01% | 3330 |
|
|
2024
Q2 | $324K | Buy |
47,163
+10,423
| +28% | +$96.9K | ﹤0.01% | 3667 |
|
|
2024
Q1 | $520K | Buy |
36,740
+18,705
| +104% | +$284K | ﹤0.01% | 3552 |
|
|
2023
Q4 | $136K | Hold |
18,035
| – | – | ﹤0.01% | 4033 |
|
|
2023
Q3 | $271K | Sell |
18,035
-65
| -0.4% | -$1.17K | ﹤0.01% | 3705 |
|
|
2023
Q2 | $288K | Sell |
18,100
-55
| -0.3% | -$578 | ﹤0.01% | 3685 |
|
|
2023
Q1 | $130K | Sell |
18,155
-63
| -0.3% | -$446 | ﹤0.01% | 4011 |
|
|
2022
Q4 | $106K | Buy |
18,218
+1,589
| +10% | +$12K | ﹤0.01% | 4073 |
|
|
2022
Q3 | $158K | Buy |
16,629
+337
| +2% | +$4.43K | ﹤0.01% | 3970 |
|
|
2022
Q2 | $195K | Sell |
16,292
-59,566
| -79% | -$624K | ﹤0.01% | 3937 |
|
|
2022
Q1 | $994K | Sell |
75,858
-3,182
| -4% | -$46.6K | ﹤0.01% | 3418 |
|
|
2021
Q4 | $1.39M | Sell |
79,040
-8,674
| -10% | -$174K | ﹤0.01% | 3405 |
|
|
2021
Q3 | $1.9M | Sell |
87,714
-4,476
| -5% | -$114K | ﹤0.01% | 3317 |
|
|
2021
Q2 | $3.23M | Sell |
92,190
-5,947
| -6% | -$320K | ﹤0.01% | 3108 |
|
|
2021
Q1 | $9.68M | Sell |
98,137
-7,016
| -7% | -$842K | ﹤0.01% | 2312 |
|
|
2020
Q4 | $11.4M | Sell |
105,153
-954
| -0.9% | -$118K | ﹤0.01% | 2168 |
|
|
2020
Q3 | $10.9M | Buy |
106,107
+11,211
| +12% | +$1.68M | ﹤0.01% | 2065 |
|
|
2020
Q2 | $19.8M | Buy |
94,896
+14,776
| +18% | +$2.62M | ﹤0.01% | 1631 |
|
|
2020
Q1 | $7.83M | Buy |
80,120
+13,265
| +20% | +$1.55M | ﹤0.01% | 2033 |
|
|
2019
Q4 | $7.7M | Buy |
66,855
+3,339
| +5% | +$294K | ﹤0.01% | 2340 |
|
|
2019
Q3 | $3.46M | Buy |
63,516
+3,236
| +5% | +$365K | ﹤0.01% | 2767 |
|
|
2019
Q2 | $7.17M | Sell |
60,280
-151
| -0.2% | -$12.5K | ﹤0.01% | 2353 |
|
|
2019
Q1 | $3.17M | Buy |
60,431
+4
| +0% | +$162 | ﹤0.01% | 2815 |
|
|
2018
Q4 | $1.9M | Sell |
60,427
-928
| -2% | -$37.7K | ﹤0.01% | 3083 |
|
|
2018
Q3 | $3.71M | Buy |
61,355
+3,431
| +6% | +$193K | ﹤0.01% | 2870 |
|
|
2018
Q2 | $3.07M | Buy |
57,924
+47,940
| +480% | +$2.88M | ﹤0.01% | 2970 |
|
|
2018
Q1 | $579K | Buy |
9,984
+1,949
| +24% | +$121K | ﹤0.01% | 3524 |
|
|
2017
Q4 | $281K | Buy |
8,035
+2,685
| +50% | +$88.4K | ﹤0.01% | 3699 |
|
|
2017
Q3 | $195K | Buy |
5,350
+2,127
| +66% | +$59K | ﹤0.01% | 3803 |
|
|
2017
Q2 | $80K | Sell |
3,223
-18,802
| -85% | -$514K | ﹤0.01% | 4013 |
|
|
2017
Q1 | $595K | Sell |
22,025
-245
| -1% | -$6.97K | ﹤0.01% | 3488 |
|
|
2016
Q4 | $646K | Buy |
22,270
+144
| +0.7% | +$4.71K | ﹤0.01% | 3470 |
|
|
2016
Q3 | $910K | Sell |
22,126
-14,949
| -40% | -$567K | ﹤0.01% | 3371 |
|
|
2016
Q2 | $1.17M | Buy |
37,075
+15,591
| +73% | +$704K | ﹤0.01% | 3298 |
|
|
2016
Q1 | $1.11M | Sell |
21,484
-234
| -1% | -$13.1K | ﹤0.01% | 3218 |
|
|
2015
Q4 | $2.07M | Buy |
21,718
+767
| +4% | +$67.4K | ﹤0.01% | 3045 |
|
|
2015
Q3 | $1.73M | Buy |
20,951
+10,748
| +105% | +$1.37M | ﹤0.01% | 3118 |
|
|
2015
Q2 | $1.66M | Buy |
10,203
+1,957
| +24% | +$660K | ﹤0.01% | 3147 |
|
|
2015
Q1 | $3.34M | Buy |
8,246
+1,125
| +16% | +$476K | ﹤0.01% | 2777 |
|
|
2014
Q4 | $3.85M | Buy |
7,121
+5,673
| +392% | +$2.19M | ﹤0.01% | 2665 |
|
|
2014
Q3 | $495K | Buy |
+1,448
| New | +$431K | ﹤0.01% | 3573 |
|
Northern Trust's ADVM Position: Q4 2025 in Review
Northern Trust sold out of Adverum Biotechnologies (ADVM) in Q4 2025, closing a stake of 28,058 shares — an estimated $127K sold.
Northern Trust first reported a position in ADVM in Q3 2014 and held it in 45 quarters. The position peaked at $19.8M in Q2 2020. 0 funds tracked by Wall St. Rank hold ADVM as of Q4 2025.
- Northern Trust reported no remaining Adverum Biotechnologies position as of Q4 2025 after selling out during the quarter.
- Northern Trust sold 28,058 Adverum Biotechnologies shares in Q4 2025, an estimated $127K.
- Northern Trust first reported a position in Adverum Biotechnologies in Q3 2014 and held it in 45 quarters.
- Northern Trust's Adverum Biotechnologies position peaked at $19.8M in Q2 2020.
- 0 funds tracked by Wall St. Rank held Adverum Biotechnologies as of Q4 2025.
Based on Northern Trust's 13F filing for Q4 2025, filed 17 Feb 2026.